Hints and tips:
Showing results for SHIRE, LLC
...West Realm Shires Inc is the US-facing offshoot, commonly referred to as FTX US, which was excluded from Binance’s quickly-abandoned rescue proposal....
...In the latest sign of how eager boardrooms are sparking a record number of “megadeals”, Japan’s top drugmaker Takeda revealed it was weighing a $40bn takeover of Irish rival Shire....
...Last year, Mr Ferguson took a 0.4 per cent stake in the $40.2bn drugmaker Shire, and is pushing the UK-listed company to spin off some of its divisions or possibly put itself up for sale....
...Corporate earnings for Thursday include Siemens, BMW, Serco, Cobham, London Stock Exchange, Inmarsat, Shire, Axa and Aviva....
...Investors in drugmaker Shire staged a rebellion over executive pay on Thursday, with 49.45 per cent of votes in a ballot to approve its remuneration report cast against its pay for top directors....
...Shire The biggest potential protest on Thursday is at Shire where two big shareholder advisory groups are recommending votes against the company’s non-binding remuneration report for 2015....
...One head of corporate governance at a big UK investment house said: “I think Shire could lose this....
...People close to Shire insist it was justified because Mr Ornskov has transformed the business, delivered better growth than peers and outperformed the market....
...However, the funds eventually recovered much of the loss after Shire’s share price rebounded. “This is Shire-AbbVie, part deux,” said one hedge fund trader....
...Weir, the engineering group, Shire, the pharmaceutical company, and CRH, the building materials business, all experienced large-scale rebellions against pay awards to their chief executives, while Barclays...
...In 2014, AbbVie pulled the plug on its $55bn takeover of Ireland-based Shire — another “inversion” that would have enabled it to slash its US tax bill — following a similar putative rule change by the US...
...JPMorgan, which was also advising Pharmacyclics, had only just last year been leading AbbVie’s £32bn deal to buy Shire of the UK, which eventually collapsed....
...AbbVie’s chief executive, Richard Gonzalez, was under pressure to explain what life after Humira would look like, following his botched attempt to buy the UK’s Shire for £32bn — a deal that was torpedoed...
...Other big transactions, most notably AbbVie’s £32bn takeover of Shire, collapsed after the US Treasury rewrote the rules....
...The collapse of drugmaker Abbvie’s attempted takeover of its UK rival Shire wiped nearly 10 per cent off the Monaco based Tyrus Capital $1.4bn event fund, as well as denting the fortunes of Davidson Kempner...
...Deborah Shire is to move from her current role as global head of business development at Axa Real Estate to become head of structured finance for Axa IM in September, replacing Laurent Gueunier who is leaving...
...Possible targets include faster-growing rivals, such as London-listed Shire, or Amlin in the US, which enjoyed a 60 per cent jump in its shares this week on reports that it rejected a takeover approach from...
...Separately, Shire, the UK-quoted speciality drug company, reported first-quarter earnings per share up 22 per cent to $1.23 on sales up 19 per cent to $972m....
...Shire , the drugmaker, rose 1.1 per cent to £20.02 amid a retread of gossip about potential bidders....
...Drugmaker Shire firmed by 1.6 per cent to £18.19 after the US Food and Drug Administration said in a preliminary ruling that it would not require hyperactivity drugs to carry a label warning about the potential...
...Shire gained 1.6 per cent to £17.96 on an upgrade from Morgan Stanley, its house broker....
...Shire was in the spotlight on Wednesday amid suggestions that it could dispose of its blockbuster drugs....
...And second, in the world of Tory rural chic portrayed in Rachel Johnson’s Shire Hell, owning a Gloucester Old Spot pig seems de rigueur....
...Shire was the top blue-chip performer, up 5.7 per cent to 842½p after Goldman Sachs added the drugmaker to its “conviction buy” list....
...Shares in Shire closed 4.4 per cent lower at 946½p after Sanford Bernstein downgraded its rating on Shire to “underperform”, citing sluggish sales of the drug....
International Edition